Generation Bio Co. (GBIO)
NASDAQ: GBIO
· Real-Time Price · USD
5.98
-0.02 (-0.33%)
At close: Sep 02, 2025, 3:59 PM
-0.33% (1D)
| Bid | 5.87 |
| Market Cap | 40.28M |
| Revenue (ttm) | 21.23M |
| Net Income (ttm) | -72.42M |
| EPS (ttm) | -10.84 |
| PE Ratio (ttm) | -0.55 |
| Forward PE | -2.14 |
| Analyst | Hold |
| Ask | 6.26 |
| Volume | 56,432 |
| Avg. Volume (20D) | 361,261 |
| Open | 5.99 |
| Previous Close | 6.00 |
| Day's Range | 5.89 - 6.03 |
| 52-Week Range | 3.00 - 29.10 |
| Beta | 2.67 |
About GBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Generation Bio Co. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+63.21%
Generation Bio shares are trading higher after the...
Unlock content with
Pro Subscription
3 weeks ago
+0.25%
Generation Bio shares are trading higher after the company announced new data demonstrating that its cell-targeted lipid nanoparticle system selectively delivered siRNA to T cells in non-human primates.
2 months ago · https://www.defenseworld.net
Squarepoint Ops LLC Takes Position in Generation Bio Co. (NASDAQ:GBIO)Squarepoint Ops LLC purchased a new position in Generation Bio Co. (NASDAQ:GBIO – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities...